STOCK TITAN

Sage Therapeutics to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Sage Therapeutics, a Nasdaq-listed biopharmaceutical company focused on developing treatments for brain disorders, will host a live webcast on August 3, 2021, at 8:00 a.m. ET. The session aims to announce the company’s second quarter 2021 financial results and highlight recent business developments. Investors can access the webcast on Sage's investor page. A replay will be available two hours post-event, archived for up to 30 days. Sage continues its mission of innovating therapies to enhance brain health and transform treatments for depression and neurological disorders.

Positive
  • Upcoming announcement of second quarter 2021 financial results may provide insights into company performance.
  • Continued focus on developing novel therapies for brain health showcases the company's commitment to innovation.
Negative
  • None.

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, August 3, 2021 at 8:00 a.m. ET to announce second quarter 2021 financial results and discuss recent business updates.

The webcast can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

FAQ

What date will Sage Therapeutics announce its second quarter 2021 financial results?

Sage Therapeutics will announce its second quarter 2021 financial results on August 3, 2021.

Where can I listen to Sage Therapeutics' financial results webcast?

The webcast for Sage Therapeutics' financial results can be accessed on the investor page of their website.

Will there be a replay of the Sage Therapeutics financial results announcement?

Yes, a replay of the webcast will be available approximately two hours after the event and archived for up to 30 days.

What is the focus of Sage Therapeutics' therapy development?

Sage Therapeutics focuses on developing therapies for disorders of the brain, particularly in depression and neurology.

Sage Therapeutics, Inc

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

305.87M
53.88M
11.92%
86.51%
10.48%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE